|
Video: What is a Stock Split?
|
|
BioSante Pharmaceuticals is a pharmaceutical company focused on developing products for female sexual health and oncology. Co.'s products for female sexual health, menopause, contraception and male hypogonadism include its gel formulations of estradiol or testosterone and combinations of estrogen, progestogen and androgen. Co.'s products, either approved or in human clinical development, include LibiGel®, a once daily transdermal testosterone gel; a male testosterone gel; GVAX cancer vaccines; the Pill-Plus, a once daily use of various combinations of estrogens, progestogens and androgens; as well as Elestrin, a once daily transdermal estradiol (estrogen) gel. According to our BPAX split history records, BPAX has had 1 split. | |
|
BPAX (BPAX) has 1 split in our BPAX split history database. The split for BPAX took place on June 04, 2012. This was a 1 for 6 reverse split, meaning for each 6 shares of BPAX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.
When a company such as BPAX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the BPAX split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BPAX shares, starting with a $10,000 purchase of BPAX, presented on a split-history-adjusted basis factoring in the complete BPAX split history.
BPAX -- use the split history when considering split-adjusted past price performance. |
|
Date |
Ratio |
06/04/2012 | 1 for 6 |
|
|